Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of miR-let-7f, miR-125a, and miR-125b expression levels in sputum and serum samples of Iranians and Afghans with pulmonary tuberculosis. | Iran J Microbiol | 2023 | 37941875 | PubTator, text mining | PubMed |
| Spatial exosome analysis using cellulose nanofiber sheets reveals the location heterogeneity of extracellular vesicles. | Nat Commun | 2023 | 37938557 | PubTator, text mining | PubMed |
| Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selection. | Mol Ther Nucleic Acids | 2023 | 37928442 | PubTator, text mining | PubMed |
| Dysregulated microRNA Expression Relevant to TERT Promoter Mutations in Tonsil Cancer-A Pilot Study. | Life (Basel) | 2023 | 37895471 | PubTator, text mining | PubMed |
| Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis. | Cancers (Basel) | 2023 | 37894474 | PubTator, text mining | PubMed |
| Biomarkers in Laryngeal Squamous Cell Carcinoma: The Literature Review. | Cancers (Basel) | 2023 | 37894464 | PubTator, text mining | PubMed |
| MicroRNA Profile, Putative Diagnostic Biomarkers and RNA-Based Therapies in the Inherited Lipid Storage Disease Niemann-Pick Type C. | Biomedicines | 2023 | 37892989 | PubTator, text mining | PubMed |
| Potential factors result in diminished ovarian reserve: a comprehensive review. | J Ovarian Res | 2023 | 37880734 | PubTator, text mining | PubMed |
| SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy. | Front Endocrinol (Lausanne) | 2023 | 37876546 | PubTator, text mining | PubMed |
| Interactive mechanism between connexin43 and Cd-induced autophagic flux blockage and gap junctional intercellular communication dysfunction in rat hepatocytes. | Heliyon | 2023 | 37876489 | PubTator, text mining | PubMed |
| Effects of Quercetin Nanoemulsion on Cholesterol Efflux and MicroRNA-33/34a Expression in the Liver of Mice Fed with a High-Cholesterol Diet. | Prev Nutr Food Sci | 2023 | 37842255 | PubTator, text mining | PubMed |
| Lipid metabolism as a target for cancer drug resistance: progress and prospects. | Front Pharmacol | 2023 | 37841917 | PubTator, text mining | PubMed |
| Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance. | Cancers (Basel) | 2023 | 37835481 | PubTator, text mining | PubMed |
| Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment. | Cancers (Basel) | 2023 | 37835441 | PubTator, text mining | PubMed |
| MicroRNAs and Nonalcoholic Steatohepatitis: A Review. | Int J Mol Sci | 2023 | 37833930 | PubTator, text mining | PubMed |
| Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients. | BMC Cancer | 2023 | 37833648 | PubTator, text mining | PubMed |
| Exosomal microRNA/miRNA Dysregulation in Respiratory Diseases: From Mycoplasma-Induced Respiratory Disease to COVID-19 and Beyond. | Cells | 2023 | 37830635 | PubTator, text mining | PubMed |
| Advances in the regulation of adipogenesis and lipid metabolism by exosomal ncRNAs and their role in related metabolic diseases. | Front Cell Dev Biol | 2023 | 37791070 | PubTator, text mining | PubMed |
| Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications. | Front Immunol | 2023 | 37767098 | PubTator, text mining | PubMed |
| The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target. | Int J Mol Sci | 2023 | 37762023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=6